BC
CMD

Bartlett & Co’s Cantel Medical Corporation CMD Stock Holding History

Bartlett & Co’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15
Closed -$1K – 1209
2020
Q4 		$1K Buy
+15
New +$880 ﹤0.01% 1088
2015
Q1 		– Sell
-87
Closed -$4K – 810
2014
Q4 		$4K Buy
+87
New +$3.55K ﹤0.01% 729

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Bartlett & Co's CMD Position: Q1 2021 in Review

Bartlett & Co sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 15 shares — an estimated $1K sold.

Bartlett & Co first reported a position in CMD in Q4 2014 and held it in 2 quarters. The position peaked at $4K in Q4 2014. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Bartlett & Co reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Bartlett & Co sold 15 Cantel Medical Corporation shares in Q1 2021, an estimated $1K.
  • Bartlett & Co first reported a position in Cantel Medical Corporation in Q4 2014 and held it in 2 quarters.
  • Bartlett & Co's Cantel Medical Corporation position peaked at $4K in Q4 2014.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Bartlett & Co's 13F filing for Q1 2021, filed 19 Apr 2021.